Related Experiment Videos

Polymorphonuclear leukocyte lysosome activities and lymphocyte transformation in multiple sclerosis and some other

European Neurology
|January 1, 1976
PubMed

Insights

Polymorphonuclear leukocyte (PMNL) lysosomes show decreased acid hydrolases in multiple sclerosis (MS) patients. This suggests PMNLs play a role in MS pathogenesis and immune cell stimulation.

Area of Science:

  • Neuroimmunology
  • Cellular Biology
  • Pathology

Background:

  • Polymorphonuclear leukocytes (PMNLs) are key immune cells.
  • Lysosomes within PMNLs contain various enzymes.
  • Dysfunction in PMNLs is implicated in autoimmune diseases.

Purpose of the Study:

  • To investigate the role of PMNL lysosomes in central nervous system (CNS) lesions.
  • To specifically examine PMNL lysosomal activity in multiple sclerosis (MS) patients.
  • To compare PMNL activity in MS with other CNS conditions.

Main Methods:

  • Analysis of peripheral blood PMNL lysosomal granules.
  • Assay of acid hydrolase activity in PMNLs.
  • Evaluation of lysosome protein mitogenic potency.

Main Results:

  • A significant decrease in acid hydrolases was observed in peripheral blood PMNL lysosomal granules of MS patients.
  • An increase in the mitogenic potency of lysosome proteins was noted in MS patients.
  • Other CNS lesions (apoplexy, brain tumors, brain trauma, epilepsy) did not exhibit similar MS-like PMNL activities.

Conclusions:

  • PMNL lysosomes exhibit distinct alterations in multiple sclerosis.
  • These findings suggest a potential role for PMNLs in MS pathogenesis.
  • PMNLs may contribute to the stimulation of immunocompetent cells in MS.

Related Concept Videos